WHO recommendation on antispasmodic agents for prevention of delay in labour 

Antispasmodic tablets

WHO recommendation on antispasmodic agents for prevention of delay in labour 

 

Recommendation

The use of antispasmodic agents for prevention of delay in labour is not recommended.

(Not recommended)

 

Publication history

First published: February 2018

Updated: Update planned

Assessed as up-to-date: February 2018 

 

Remarks

  • This recommendation has been integrated from the WHO recommendations for augmentation of labour, in which the GDG for that guideline determined it to be a conditional recommendation based on very low-quality evidence.  
  • The GDG noted that the available data were too heterogeneous with respect to the participants and interventions to permit wide applicability of the results. The shortening in the length of the first stage of labour by one hour was considered clinically inconsequential, as it did not translate into improvement in the other critical maternal or infant outcomes. The GDG placed high value on safety issues, which were poorly reported, and chose not to recommend the practice until new information demonstrating clinical benefits with minimal risks becomes available.  
  • The GDG considers the effectiveness of the use of antispasmodic agents for the treatment of labour delay as a research priority.
  • The evidence supporting this recommendation can be found in the source guideline document, available at:

WHO recommendation on the use of antispasmodic agents for prevention of delay in labour

http://who.int/iris/bitstream/10665/112826/1/WHO_RHR_14.15_eng.pdf

 

Related links

WHO recommendations on intrapartum care for a positive childbirth experience

(2018) - full document and evidence tables

Managing Complications in Pregnancy and Childbirth: A guide for midwives and doctors

Pregnancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice

WHO Programmes: Sexual and Reproductive health

Maternal Health